August Bioservices Expands Operations at Nashville, Tennessee, Campus
11/19/2020
The first phase of the project, which will be completed in late 2021, will involve the targeted expansion of August Bioservices’ existing Nashville facility, adding high-value technologies such as lyophilization and terminal sterilization to its existing cGMP fill and finish manufacturing capabilities.
The second phase of the project will see August Bioservices construct a new, state-of-the-art, drug development and manufacturing facility that will feature multiple high-speed production lines capable of delivering commercial scale throughput across a wide array of sterile injectables containers, including vials, IV bags and prefilled syringes.
Taken together, the expansion activities will enable August Bioservices to grow its footprint in drug development and manufacturing services and allow the company to pursue attractive later-stage clinical development as well as commercial manufacturing opportunities.
“We couldn’t be more delighted to be laying down roots and creating jobs in Tennessee! The investments that we are making to expand our workforce, our capabilities and our capacity will enable us to better serve our global customers and to support the growing biotech industry here in Nashville. Most importantly, everyone at August Bioservices is extremely proud to advance work that provides lifesaving treatments to patients that need them,” Jenn Adams, CEO, August Bioservices said.
“It’s always a great day when we can announce over 180 new jobs in Tennessee. Now more than ever, we are seeing the benefits of ground-breaking clinical research, and August Bioservices is a major contributor. I’d like to thank the team at August Bioservices for their commitment to our state and for this additional investment in Nashville,” said Governor Bill Lee.
“Tennessee continues to make a name for itself as a top place for the healthcare and life sciences sector. When companies like August Bioservices choose to further invest in Tennessee, their actions speak volumes to the pro-business and pro-science environment we have created in our state. We appreciate August Bioservices for creating these new, family wage jobs in Nashville and for its continued partnership,” added Bob Rolfe, Commissioner of TNECD.
August Bioservices provides drug discovery, drug development and drug manufacturing services in support of the global pharmaceutical industry. The company is expanding its capabilities to become a preferred, specialized, one-stop-shop CDMO for clinical and commercial injectable therapies.
Project Announcements
Blue Core Labs Establishes Beaver, Utah, Operations
05/16/2022
Breeze Aviation Group Expands Provo, Utah, Hub
05/16/2022
Milwaukee Tool Expands Menomonee Falls, Wisconsin, Operations
05/16/2022
Trison Wells Establishes South Carolina, Operations
05/16/2022
France-Based Saint-Gobain ADFORS North America Expands Dublin, Georgia, Plant
05/13/2022
Moderna Plans Quebec, Canada, Manufacturing-Operations Campus
05/13/2022
Most Read
-
The Evolution of the Megasite
Q2 2022
-
36th Annual Corporate Survey: Executives Focus on Labor, Energy, Shipping Costs
Q1 2022
-
The 2021 Top States for Doing Business Reflect Their Locational Advantages
Q3 2021
-
18th Annual Consultants Survey: Access to Major Markets and Skilled Labor Are Clients’ Primary Concerns
Q1 2022
-
2021 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
Q2 2021
-
Driving Into An Electric Vehicle Future
Q1 2022
-
Innovative and Collaborative Design Sets the Stage for Life Science Innovation
Q2 2022